We also showed that BRAFT1799A-induced thyroid oncogenesis model in vivo (Tg-BRAF transgenic mice) increased FAM83F expression in 5-week-old PTC mice, altogether indicating a cross regulation of FAM83F and MAPK signaling. The gene discussed is BRAF; the disease is thyroid gland disorder.